St Walburga Hospital, Meschede: Prof. Dr. med. Weber;
Private Practice at the Medical Care Center, Dialysis Center, Cuxhaven: Prof.
Dr. med. Anlauf
Background: The introduction of invasive treatments, some of
which are irreversible, for the entity called treatment-resistant hypertension
(TRH) creates the need for a comprehensive discussion of the diagnostic
evaluation that TRH requires and the available options for its conservative
treatment.
Method: The pertinent literature is selectively reviewed in
the light of the authors‘ longstanding clinical experience.